GLP1R and metabolic dysfunction-associated steatotic liver disease: The search strategy employed Boolean operators using the following terms: (“semaglutide” OR “GLP-1 receptor agonist”) AND (“MASLD” OR “MASH” OR “NASH” OR “NAFLD” OR “non alcoholic fatty liver disease” OR “non alcoholic steatohepatitis” OR “metabolic dysfunction associated steatotic liver diseases: OR “metabolic dysfunction associated steatohepatitis”).